RAME treatment increased the mRNA levels of ATG genes (ULK1, ATG5, BECN1, ATG7, ATG12, and ATG13) dose dependently in cervical cancer cells (Fig. 4f, g). The gene discussed is ATG5; the disease is cervical carcinoma.